Cefditoren

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cefditoren
Systematic (IUPAC) name
(7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((Z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Clinical data
Trade names Spectracef
AHFS/Drugs.com monograph
MedlinePlus a605003
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 104145-95-1 N
ATC code J01DD16
PubChem CID 9870843
DrugBank DB01066
ChemSpider 8046534 YesY
UNII 81QS09V3YW YesY
KEGG D07639 N
ChEBI CHEBI:59343 YesY
Chemical data
Formula C19H18N6O5S3 
Mol. mass 506.58 g/mol
 N (what is this?)  (verify)

Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.

Cefditoren is also marketed under the name Meiact.[1]

Contents

Clinical use [edit]

Indications [edit]

Cefditoren is used to treat uncomplicated skin and skin structure infections, community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis (ABECB), pharyngitis, and tonsillitis.

Formulations [edit]

Cefditoren is available as 200 and 400 mg tablets. It can be formulated as the prodrug cefditoren pivoxil.

Chemical structure of cefditoren pivoxil

References [edit]

External links [edit]